Tammela TL - Search Results

1

Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men.

Siltari A, Murtola TJ, Kausz J, Talala K, Taari K, Tammela TL, Auvinen A. Siltari A, et al. Among authors: tammela tl. Acta Oncol. 2023 Dec;62(12):1898-1904. doi: 10.1080/0284186X.2023.2278189. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37971326 Clinical Trial.

2

Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.

Auvinen A, Tammela T, Stenman UH, Uusi-Erkkilä I, Leinonen J, Schröder FH, Hakama M. Auvinen A, et al. Br J Cancer. 1996 Aug;74(4):568-72. doi: 10.1038/bjc.1996.402. Br J Cancer. 1996. PMID: 8761371 Free PMC article. Clinical Trial.

3

A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate.

Pétas A, Talja M, Tammela T, Taari K, Lehtoranta K, Välimaa T, Törmälä P. Pétas A, et al. J Urol. 1997 Jan;157(1):173-6. J Urol. 1997. PMID: 8976244 Clinical Trial.

4

The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate.

Pétas A, Talja M, Tammela TL, Taari K, Välimaa T, Törmälä P. Pétas A, et al. Among authors: tammela tl. Br J Urol. 1997 Sep;80(3):439-43. doi: 10.1046/j.1464-410x.1997.00308.x. Br J Urol. 1997. PMID: 9313664 Clinical Trial.

5

European randomized study of prostate cancer screening: first-year results of the Finnish trial.

Määttänen L, Auvinen A, Stenman UH, Rannikko S, Tammela T, Aro J, Juusela H, Hakama M. Määttänen L, et al. Br J Cancer. 1999 Mar;79(7-8):1210-4. doi: 10.1038/sj.bjc.6690194. Br J Cancer. 1999. PMID: 10098761 Free PMC article. Clinical Trial.

6

[Why screen for prostate cancer in Finland?].

Auvinen A, Hakama M, Rannikko S, Stenman UH, Tammela T. Auvinen A, et al. Duodecim. 1996;112(14):1241-3. Duodecim. 1996. PMID: 10596093 Finnish. No abstract available.

7

[About Psa-screening].

Hakama M, Auvinen A, Stenman UH, Tammela T. Hakama M, et al. Duodecim. 1996;112(14):1314-6. Duodecim. 1996. PMID: 10596108 Finnish. No abstract available.

8

Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970-1994.

Aho M, Koivisto AM, Tammela TL, Auvinen A. Aho M, et al. Among authors: tammela tl. Environ Health Perspect. 2000 May;108(5):463-5. doi: 10.1289/ehp.00108463. Environ Health Perspect. 2000. PMID: 10811575 Free PMC article.

9

Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen.

Finne P, Auvinen A, Koistinen H, Zhang WM, Määttänen L, Rannikko S, Tammela T, Seppälä M, Hakama M, Stenman UH. Finne P, et al. J Clin Endocrinol Metab. 2000 Aug;85(8):2744-7. doi: 10.1210/jcem.85.8.6725. J Clin Endocrinol Metab. 2000. PMID: 10946875 Clinical Trial.

10

Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network.

Finne P, Finne R, Auvinen A, Juusela H, Aro J, Määttänen L, Hakama M, Rannikko S, Tammela TL, Stenman U. Finne P, et al. Among authors: tammela tl. Urology. 2000 Sep 1;56(3):418-22. doi: 10.1016/s0090-4295(00)00672-5. Urology. 2000. PMID: 10962306 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters